Back to companies

Deciphera Pharmaceuticals LLC: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Deciphera Pharmaceuticals LLC patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
US20230390255A1 Application Compositions of 1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea A61K31/4375; A61K47/38; A61K9/0053; A61K9/10 December 07, 2023
US20230390258A1 Application Compositions of 1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea A61K31/4375; A61K47/38; A61K9/0053; A61K9/10 December 07, 2023
US20230390257A1 Application Compositions of 1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea A61K31/4375; A61K47/38; A61K9/0053; A61K9/10 December 07, 2023
US20230390256A1 Application Compositions of 1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea A61K31/4375; A61K47/38; A61K9/0053; A61K9/10 December 07, 2023
RS64755B1 Grant Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof A61K31/4545; A61K31/519; A61K31/55; A61K31/553; A61K45/06; A61P35/00; A61P35/04; C07D401/14; C07D403/12; C07D403/14; C07D405/14; C07D413/14; Y02A50/30 November 30, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Register your interest

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer